scispace - formally typeset
Search or ask a question
Institution

Chinese PLA General Hospital

HealthcareBeijing, China
About: Chinese PLA General Hospital is a healthcare organization based out in Beijing, China. It is known for research contribution in the topics: Medicine & Population. The organization has 18037 authors who have published 12349 publications receiving 184803 citations. The organization is also known as: 301 Military Hospital.


Papers
More filters
Journal ArticleDOI
03 Nov 2015-PLOS ONE
TL;DR: Patients with infected nonunion of tibia and femur treated by Ilizarov methods had a low rate of poor bone and functional results and may be a good choice for the treatment of infected non unions, according to a systematic review.
Abstract: Background Infected nonunion of tibia and femur are common in clinical practice, however, the treatment of these diseases has still been a challenge for orthopaedic surgeons. Ilizarov methods can eradicate infection, compensate bone defects and promote the bone union through progressive bone histogenesis. The objective of this systematic review was to review current available studies reporting on Ilizarov methods in the treatment of infected nonunion of tibia and femur, and to perform meta-analysis of bone and functional results and complications to evaluate the efficacy of Ilizarov methods.

87 citations

Journal ArticleDOI
TL;DR: The mDCF regimen, compared with CF, significantly prolonged PFS and OS and enhanced ORR of Chinese patients with advanced gastric cancer and achieved efficacy comparable to that of DCF but with fewer toxicities, which is appropriate for the Chinese population.
Abstract: Background The V325 study showed that docetaxel, cisplatin, and fluorouracil (DCF) prolonged overall survival (OS) of patients with advanced gastric cancer, but with a high incidence of dose-limiting toxicities. We investigated the efficacy and safety of a modified DCF (mDCF) regimen for Chinese patients with advanced gastric cancer.

87 citations

Journal ArticleDOI
TL;DR: In the intermediate term, US-guided percutaneous MWA appears to be a safe and effective technique for the management of R CC, especially small RCC, in selected patients.
Abstract: In the intermediate term, US-guided percutaneous microwave ablation appears to be a safe and effective technique for management of renal cell carcinomas, especially those that are small, in selected patients.

87 citations

Journal ArticleDOI
TL;DR: The present study provides a promising approach for in vivo cartilage repair without cell transplantation and demonstrates that the composite scaffold could enhance endogenous stem cell homing and chondrogenic differentiation and significantly improve the therapeutic outcome of chondral defects.
Abstract: Even small cartilage defects could finally degenerate to osteoarthritis if left untreated, owing to the poor self-healing ability of articular cartilage. Stem cell transplantation has been well implemented as a common approach in cartilage tissue engineering but has technical complexity and safety concerns. The stem cell homing-based technique emerged as an alternative promising therapy for cartilage repair to overcome traditional limitations. In this study, we constructed a composite hydrogel scaffold by combining an oriented acellular cartilage matrix (ACM) with a bone marrow homing peptide (BMHP)-functionalized self-assembling peptide (SAP). We hypothesized that increased recruitment of endogenous stem cells by the composite scaffold could enhance cartilage regeneration. Methods: To test our hypothesis, in vitro proliferation, attachment and chondrogenic differentiation of rabbit mesenchymal stem cells (MSCs) were tested to confirm the bioactivities of the functionalized peptide hydrogel. The composite scaffold was then implanted into full-thickness cartilage defects on rabbit knee joints for cartilage repair, in comparison with microfracture or other sample groups. Stem cell recruitment was monitored by dual labeling with CD29 and CD90 under confocal microcopy at 1 week after implantation, followed by chondrogenic differentiation examined by qRT-PCR. Repaired tissue of the cartilage defects was evaluated by histological and immunohistochemistry staining, microcomputed tomography (micro-CT) and magnetic resonance imaging (MRI) at 3 and 6 months post-surgery. Macroscopic and histological scoring was done to evaluate the optimal in vivo repair outcomes of this composite scaffold. Results: The functionalized SAP hydrogels could stimulate rabbit MSC proliferation, attachment and chondrogenic differentiation during in vitro culture. At 7 days after implantation, increased recruitment of MSCs based on CD29+ /CD90+ double-positive cells was found in vivo in the composite hydrogel scaffold, as well as upregulation of cartilage-associated genes (aggrecan, Sox9 and type II collagen). After 3 and 6 months post-surgery, the articular cartilage defect in the composite scaffold-treated group was fully covered with cartilage-like tissue with a smooth surface, which was similar to the surrounding native cartilage, according to the results of histological and immunohistochemistry staining, micro-CT and MRI analysis. Macroscopic and histological scoring confirmed that the quality of cartilage repair was significantly improved with implantation of the composite scaffold at each timepoint, in comparison with microfracture or other sample groups. Conclusion: Our findings demonstrated that the composite scaffold could enhance endogenous stem cell homing and chondrogenic differentiation and significantly improve the therapeutic outcome of chondral defects. The present study provides a promising approach for in vivo cartilage repair without cell transplantation. Optimization of this strategy may offer great potential and benefits for clinical application in the future.

87 citations

Journal ArticleDOI
01 May 2017-BMJ Open
TL;DR: The abnormal haemostatic profiles may contribute to the elevated risk of thrombotic events but further longer-term study with large samples is still required to more precisely determine the relationship between the elevation of procoagulant factors and clinical outcomes.
Abstract: Objectives Thromboembolic events are the major factor affecting the prognosis of patients with chronic kidney disease (CKD) Haemostatic alterations are possible causes of these complications, but their roles remain poorly characterised In the prospective observational study, we investigated the entire coagulation process in patients with CKD to elucidate the mechanisms of their high thromboembolic risk Methods A total of 95 patients with CKD and 20 healthy controls who met the inclusion criteria were consecutively recruited from September 2015 to March 2016 The platelet count, platelet aggregation, von Willebrand factor antigen (vWF:Ag), vWF ristocetin cofactor activity (vWF:RCo), fibrinogen, factor V (FV), FVII, FVIII, antithrombin III, protein C, protein S, D-dimer, standard coagulation tests and thromboelastography were measured in patients with CKD and controls Associations between the estimated glomerular filtration rate (eGFR) and haemostatic biomarkers were tested using multivariable linear regression Results The adjusted and unadjusted levels of vWF:Ag, vWF:RCo, fibrinogen, FVII, FVIII and D-dimer were significantly higher in patients with CKD than that in the healthy controls, and were elevated with CKD progression However, after adjustment for baseline differences, platelet aggregation and thromboelastography parameters showed no significant differences between patients with CKD and healthy controls In the correlation analysis, vWF:Ag, vWF:RCo and FVIII were inversely associated with eGFR (r=−0359, p Conclusions Patients with CKD are characterised by endothelial dysfunction and increased coagulation, especially FVIII activity The abnormal haemostatic profiles may contribute to the elevated risk of thrombotic events but further longer-term study with large samples is still required to more precisely determine the relationship between the elevation of procoagulant factors and clinical outcomes

87 citations


Authors

Showing all 18235 results

NameH-indexPapersCitations
Jie Zhang1784857221720
Gregory Y.H. Lip1693159171742
Chao Zhang127311984711
Hong Wang110163351811
Shuji Ogino10654943073
Li Chen105173255996
Jing Wang97112353714
Wei Wang95354459660
Zhiguo Yuan9363328645
Tai Hing Lam93116851646
Christopher P. Crum8741232399
Guozhen Shen8442223992
Jing-Feng Li8150723434
Zongjin Li8063022103
Wan Yee Lau7646321257
Network Information
Related Institutions (5)
Nanjing Medical University
37.9K papers, 635.8K citations

92% related

Capital Medical University
47.2K papers, 811.2K citations

92% related

Second Military Medical University
20.4K papers, 449.4K citations

91% related

Peking Union Medical College
61.8K papers, 1.1M citations

90% related

Fudan University
117.9K papers, 2.6M citations

86% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202358
2022242
20212,017
20201,853
20191,159
2018944